ATX
Click for more information
0.00% 7.0¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-2

  1. Dimitrios63
    55 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    27/03/24
    09:30
    Post #: 73076262
    That’s 11 patients recruited thus far with 26 in total needed for 2A.

    They expect to update the market in regards to efficacy in Q3/24 which sounds more realistic.
    Last edited by Dimitrios63: 27/03/24
    ATX Price at posting: 7.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

CCO Calmer Co taps investors for $2M
right-arrow Created with Sketch.
TLX Telix kicks off $300M NASDAQ IPO offer, backed by Morgan Stanley
right-arrow Created with Sketch.
I88 Infini boosts WA uranium holdings with Bellah Bore East acquisition
right-arrow Created with Sketch.
BB1 BlinkLab jumps as Dutch dementia study kicks off
right-arrow Created with Sketch.
AZY Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $19.01M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 146 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 147559 1
View Market Depth
Last trade - 10.18am 06/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.